Article info

Download PDFPDF

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Free

Authors

  1. Correspondence to Dr Elizabeth R Volkmann, Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA; evolkmann{at}mednet.ucla.edu
View Full Text

Citation

Volkmann ER, Tashkin DP, Sim M, et al
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

Publication history

  • Received May 4, 2018
  • Revised September 27, 2018
  • Accepted October 16, 2018
  • First published November 8, 2018.
Online issue publication 
December 18, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.